Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-06-03
1995-11-14
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514915, A61K 3804, C07K 5037
Patent
active
054666732
ABSTRACT:
This invention relates to an intraocular irrigating composition containing a compound of the following formula or a pharmacologically acceptable salt thereof ##STR1## wherein R.sub.1 and R.sub.2 are the same or different and each represents a hydrogen atom or a methyl group.
The glutathione derivative contained in the intraocular irrigating solution of this invention is not only effective in protecting the intraocular tissues on the occasion of ophthalmic surgery but effectively inhibits precipitation of the calcium contained. Therefore, the intraocular irrigating solution of this invention is very stable and can be used with advantage in various kinds of ophthalmic surgery such as cataract surgery and transplantation of the cornea, iris and vitreous body.
REFERENCES:
patent: 4837021 (1989-06-01), Andermann et al.
Ogata Kazumi
Ohmori Shinji
Sakaue Takahiro
Tsuruoka Hideki
Prickril Benet
Senju Pharmaceutical Co. Ltd.
Warden Jill
LandOfFree
Method of inhibiting calcium precipitation in an intraocular irr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting calcium precipitation in an intraocular irr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting calcium precipitation in an intraocular irr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1220976